Feasibility Study of Novice-Performed Lung Ultrasound for Pneumothorax Detection After Cardiac Surgery
Launched by JACOBO MORENO GARIJO · Jun 4, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether medical trainees can effectively use lung ultrasound to detect a condition called pneumothorax, which is a collapsed lung, in patients who have recently undergone heart surgery. The study will involve adults who are 18 years or older and are scheduled to have their chest tubes removed in the cardiovascular intensive care unit (CVICU). However, those with certain lung conditions or other specific health issues may not be eligible to participate.
During the study, once the chest tubes are taken out, a trained medical trainee will use a small ultrasound device to check the patient's lungs right at their bedside. Patients will also receive a chest X-ray, which is a standard procedure, and the results from both tests will be compared. The main goal is to see if trainees can learn to use the ultrasound safely and accurately, which could help inform future larger studies on this technique.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Undergoing cardiac surgery
- • Scheduled for chest and/or mediastinal chest tube removal in the cardiovascular intensive care unit (CVICU)
- Exclusion Criteria:
- * Severe chronic lung disease that may impair lung ultrasound interpretation, including:
- • Subcutaneous emphysema
- • COPD or emphysema with FEV₁ \< 50% predicted
- • Interstitial lung disease with FEV₁ \< 75% predicted
- • Documented history of pneumothorax prior to chest tube removal requiring intervention
- • Mechanical ventilation at the time of eligibility screening
- • Inability to undergo lung ultrasound or chest X-ray (e.g., due to hemodynamic instability or positioning limitations)
About Jacobo Moreno Garijo
Jacobo Moreno Garijo is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, he leads initiatives that bridge the gap between scientific discovery and clinical application. His expertise encompasses the design, implementation, and management of clinical trials, ensuring compliance with regulatory standards while prioritizing participant safety and data integrity. Through collaboration with healthcare professionals and research institutions, Jacobo Moreno Garijo aims to contribute significantly to the development of new treatments and enhance the overall quality of care in the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Angela Jerath, MD
Study Chair
Sunnybrook Health Sciences Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported